UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Total Assets Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual total assets in 2023 was 685.92 Million TWD , up 65.56% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 810.1 Million TWD , up 23.64% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported annual total assets of 414.31 Million TWD in 2022, up 39.16% from previous year.
  • UnicoCell Biomed Co., Ltd. reported annual total assets of 297.71 Million TWD in 2021, down -23.9% from previous year.
  • UnicoCell Biomed Co., Ltd. reported quarterly total assets of 655.21 Million TWD for 2024 Q1, down -4.48% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported quarterly total assets of 734.5 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Total Assets of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 685.92 Million TWD 65.56%
2022 414.31 Million TWD 39.16%
2021 297.71 Million TWD -23.9%
2020 391.22 Million TWD 0.0%
2019 - TWD 0.0%

Peer Total Assets Comparison of UnicoCell Biomed Co., Ltd.

Name Total Assets Total Assets Difference
Apex Biotechnology Corp. 2.29 Billion TWD 70.138%
Sinphar Pharmaceutical Co.,Ltd. 6.25 Billion TWD 89.027%
Panion & Bf Biotech Inc. 3.23 Billion TWD 78.798%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 5.17 Billion TWD 86.737%
GenMont Biotech Incorporation 1.65 Billion TWD 58.509%
Abnova (Taiwan) Corporation 1.35 Billion TWD 49.406%
Adimmune Corporation 9.48 Billion TWD 92.768%
Tanvex BioPharma, Inc. 2.76 Billion TWD 75.178%
Polaris Group 9.09 Billion TWD 92.461%
Energenesis Biomedical CO.,LTD. 828.57 Million TWD 17.215%
PELL Bio-Med Technology Co. Ltd. 1.41 Billion TWD 51.632%